Overview
"Dr. James Casella is a professor of pediatrics and oncology at the Johns Hopkins University School of Medicine. As the Johns Hopkins’ Rainey Professor of Pediatric Hematology, Dr. Casella is chief of the Division of Pediatric Hematology at Johns Hopkins Children's and director of the Basic and Translational Research Program in Sickle Cell Disease, Comprehensive Sickle Cell Center and the Maryland Hemophilia Treatment Center at Johns Hopkins. He supervises several labs investigating the cellular and molecular basis of pediatric blood-borne diseases. He is seeking to develop better treatments for sickle cell disease and the prevention of central nervous system complications of this disorder, including stroke. Dr. Casella received his undergraduate degree in mathematics from Union College. He earned his M.D. from SUNY of Syracuse and completed a residency in pediatrics at Johns Hopkins University School of Medicine, where he was subsequently a fellow in hematology/oncology. He has been a member of the Johns Hopkins’ faculty since 1983. A research scientist as well as a clinician, he co-directs the hematology/oncology fellowship program at Johns Hopkins Hospital and is an adjunct senior investigator (Pediatric Oncology Branch) in the Division of Clinical Sciences, National Cancer Institute, National Institutes of Health. He is also director of the NHLBI-funded K12 in benign hematology program at Johns Hopkins that trains young clinician/investigators in benign hematology and transfusion medicine. Dr. Casella has served on numerous university, hospital, and advisory committees, many geared toward hematology, pediatrics and transfusion. He has received many awards from the Johns Hopkins Hospital, including the Alexander ""Buck"" Schaffer Award for Outstanding Contribution to the Teaching of House Officers. He and a colleague created the Johns Hopkins/St. Agnes Comprehensive Hemophilia Clinic to improve care for patients with the disease.".
Dr. Casella is rated as an Experienced provider by MediFind in the treatment of Hemoglobin C Disease. His top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, and Hemolytic Anemia.
His clinical research consists of co-authoring 71 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
Locations
200 North Wolfe Street, Rubenstein BLDG Lower Level, Rubenstein BLDG Lower Level, Baltimore, MD 21287
Additional Areas of Focus
Dr. Casella has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
University Of Maryland Oncology Associates PA
Jennie Law is a Hematologist Oncology specialist and a Hospital Medicine provider in Baltimore, Maryland. Dr. Law is rated as a Distinguished provider by MediFind in the treatment of Hemoglobin C Disease. Her top areas of expertise are Sickle Cell Disease, Hemoglobinopathy, Hemoglobin SC Disease, Hemoglobin E Disease, and Bone Marrow Aspiration. Dr. Law is currently accepting new patients.
Johns Hopkins University
Michael Streiff is a Hematologist in Baltimore, Maryland. Dr. Streiff is rated as an Elite provider by MediFind in the treatment of Hemoglobin C Disease. His top areas of expertise are Venous Thromboembolism (VTE), Deep Vein Thrombosis, Pulmonary Embolism, Pancreaticoduodenectomy, and Bone Marrow Aspiration.
University Of Maryland Oncology Associates PA
Ann Zimrin is a Hematologist Oncology specialist and a Hematologist in Baltimore, Maryland. Dr. Zimrin is rated as an Advanced provider by MediFind in the treatment of Hemoglobin C Disease. Her top areas of expertise are Thrombocytopenia, Sickle Cell Disease, Hemoglobinopathy, Hemoglobin C Disease, and Splenectomy. Dr. Zimrin is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- AnemiaDr. Casella isElite. Learn about Anemia.
- Congenital Hemolytic AnemiaDr. Casella isElite. Learn about Congenital Hemolytic Anemia.
- HemoglobinopathyDr. Casella isElite. Learn about Hemoglobinopathy.
- Hemolytic AnemiaDr. Casella isElite. Learn about Hemolytic Anemia.
- Sickle Cell DiseaseDr. Casella isElite. Learn about Sickle Cell Disease.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Casella isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Hemoglobin C DiseaseDr. Casella isExperienced. Learn about Hemoglobin C Disease.
- Hemoglobin E DiseaseDr. Casella isExperienced. Learn about Hemoglobin E Disease.
- Venous Thromboembolism (VTE)Dr. Casella isExperienced. Learn about Venous Thromboembolism (VTE).